Purchase Order 75P00226P00003
Award Date 1/5/26
Potential Completion Date 1/5/26
Potential Value $419K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63146, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Meridian Medical Technologies, LLC, a Pfizer subsidiary, was awarded a delivery order valued at approximately $992.7K by the Bureau of Medical Services for DuoDote autoinjectors, with completion targeted for September 29, 2025. This firm-fixed-price contract, issued on September 30, 2024, carries no small business set-aside designation and will be performed in St. Louis, Missouri. DuoDote autoinjectors represent a critical medical countermeasure combining atropine and pralidoxime chloride for...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Secret Service to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the purchase of DuoDote auto-injector packs. The contract has a ceiling value of $70,111.80 and a completion date of May 5, 2018. Meridian Medical Technologies has a history of providing medical training devices, auto-injector kits, and nerve agent antidote treatments to various federal agencies, including the Department of...
- On September 30, 2024, the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a definitive firm-fixed-price contract to Meridian Medical Technologies, LLC for the supply of Atropine & Pralidoxime Chloride Injector single-dose auto-injectors (DuoDote) for the Strategic National Stockpile. The contract has a ceiling value of approximately $129.7 million with a one-year performance period from September 30, 2025 through...
- This is a firm-fixed-price purchase order awarded by the U.S. Marshals Service Tactical Operations Division to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The $15,514.80 contract is for the delivery of auto-injectors containing the nerve agent antidotes atropine and pralidoxime. The contract does not utilize any set-aside designations. Meridian Medical Technologies is a key provider of auto-injector devices and nerve agent antidote treatments across the federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for $3,262,840.74 to provide 4522513207 ANTIDOTE TREATMENT products. Meridian Medical Technologies is a manufacturer of pharmaceutical products and medical devices, including nerve agent antidote treatments and autoinjector kits. This contract does not have a set-aside designation. Meridian has a...
- This federal contract award to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., is for the development and delivery of an FDA-approved advanced autoinjector system (AAS). The definitive contract, valued at $41,936,532.62, is a cost-plus-incentive arrangement with the U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense. The award does not utilize a small business set-aside. Meridian, a manufacturer of medical countermeasures...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,260.76 and is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This is a $1,158.49 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of epinephrine 0.3 mg auto-injectors and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors, a critical medical product used for the emergency treatment of severe allergic reactions. The contract, valued at $2,100.61, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injectors on October 7, 2025, with a ceiling value of $12,500.61. This firm fixed-price delivery order is scheduled for completion by October 8, 2025, and represents a pediatric/emergency medical supply need fulfilled through the company's existing contract vehicle. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...